Technical Analysis for XFOR - X4 Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| 200 DMA Resistance | Bearish | -0.93% | |
| Doji - Bullish? | Reversal | -0.93% | |
| Wide Bands | Range Expansion | -0.93% | |
| Fell Below 200 DMA | Bearish | -0.04% | |
| Wide Bands | Range Expansion | -0.04% | |
| Wide Bands | Range Expansion | -7.03% | |
| Wide Bands | Range Expansion | -8.34% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 22 hours ago |
| Down 2 % | about 22 hours ago |
| Down 1% | about 22 hours ago |
| 200 DMA Resistance | about 23 hours ago |
| Up 3% | about 23 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
X4 Pharmaceuticals, Inc., formerly Arsanis, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases including primary immunodeficiencies and cancer. The Company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. Its product candidates include X4P-001, X4P-002 and X4P-003.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Rare Diseases Small Molecule Treatment Of Rare Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Rare Diseases Small Molecule Treatment Of Rare Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.575 |
| 52 Week Low | 0.5723 |
| Average Volume | 3,750,428 |
| 200-Day Moving Average | 1.01 |
| 50-Day Moving Average | 1.17 |
| 20-Day Moving Average | 1.13 |
| 10-Day Moving Average | 1.06 |
| Average True Range | 0.12 |
| RSI (14) | 38.65 |
| ADX | 20.34 |
| +DI | 14.26 |
| -DI | 21.52 |
| Chandelier Exit (Long, 3 ATRs) | 1.04 |
| Chandelier Exit (Short, 3 ATRs) | 1.25 |
| Upper Bollinger Bands | 1.33 |
| Lower Bollinger Band | 0.92 |
| Percent B (%b) | 0.13 |
| BandWidth | 36.32 |
| MACD Line | -0.06 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0203 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.07 | ||||
| Resistance 3 (R3) | 1.07 | 1.05 | 1.05 | ||
| Resistance 2 (R2) | 1.05 | 1.02 | 1.04 | 1.05 | |
| Resistance 1 (R1) | 1.01 | 1.01 | 1.00 | 1.01 | 1.04 |
| Pivot Point | 0.99 | 0.99 | 0.98 | 0.98 | 0.99 |
| Support 1 (S1) | 0.95 | 0.96 | 0.94 | 0.95 | 0.91 |
| Support 2 (S2) | 0.93 | 0.95 | 0.92 | 0.91 | |
| Support 3 (S3) | 0.89 | 0.93 | 0.90 | ||
| Support 4 (S4) | 0.89 |
